Clinical Trials Directory

Trials / Sponsors / Cartesian Therapeutics

Cartesian Therapeutics

Industry · 12 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingDescartes-08 in Autoantibody Myositis
Antisynthetase Syndrome
Phase 22026-06-30
RecruitingDescartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV), Juvenile Myasthenia Gravis
Phase 1 / Phase 22026-01-14
RecruitingInvestigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia G
Myasthaenia Gravis
Phase 32025-05-06
TerminatedDescartes-15 for Patients With Relapsed/Refractory Multiple Myeloma
Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Phase 12024-06-19
Active Not RecruitingDescartes-08 for Patients With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Phase 22024-02-12
TerminatedDescartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Wh
Myeloma Multiple
Phase 22021-12-01
TerminatedDescartes-25 in Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapse Multiple Myeloma
Phase 12021-11-25
CompletedDescartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease Aft
Multiple Myeloma
Phase 22021-02-24
TerminatedStudy of Descartes-30 in Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome, Covid19
Phase 12021-02-23
Active Not RecruitingDescartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
Myasthenia Gravis, Generalized
Phase 22019-12-04
TerminatedDescartes-11 in Patients With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
Phase 12019-08-01
TerminatedAutologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma
Multiple Myeloma
Phase 12018-03-08